Since international actor Irrfan Khan announced his cancer diagnosis in February,  he has dropped out of several of his planned film projects. However, many fans are taking the fact that he recently agreed to a sequel of his hit film “Hindi Medium” as a sign that his health is currently improving.

According to reports, the creators “Hindi Medium” flew to London to speak with Khan in person and describe their vision for the film’s sequel. Khan apparently loved the script and gave his answer to go ahead instantly. The original 2017 film followed Raj and his wife Mita as they create elaborate schemes to get their daughter into an English medium school.

In this sequel, the story has moved ahead 10 years and Khan will return to play his role of Raj, the middle-class tailor who built his fortune with an empire of clothing stores. There is no news yet if Pakistani actress Saba Qamar will return to play Khan’s wife.

Taking on this new project could indicate positive news considering just two weeks ago he had to drop out of the Amazon Video series “Gormint” by the popular comedy group All India Bakchod (AIB).

Khan posted a sorrow-filled message on social media stating that the Amazon series was one of his favorite projects and he is “gutted by this development” because he worked so hard but it’s just not a feasible opportunity at the moment. It sounds like the logistics behind shooting the Amazon show and being present for treatment was too difficult to manage.

On the basis of recent developments, an update 👇

Posted by Irrfan on Monday, August 13, 2018

Khan has been residing in London during his treatment and he has said he has found new meaning in life through this difficult process. One of the things Khan has posted about is that has found clarity and has been able to discover a new, more spontaneous side of himself as he’s undergone treatment. Hopefully, Khan’s positive light and new attitude lead him to better health.

GET YOUR SLICE OF SOUTH ASIAN POP CULTURE

Sign up for our weekly newsletter.

 I read and agree to the Privacy Policy and Terms of Use.